SARS-CoV-2 (Omicron variant) vaccine, Inactivated (Beijing Institute Of Biological Products)

Omicron株新型冠状病毒灭活疫苗（北京生物制品研究所）

Report date: 2024/01/02 20:03:52

Base Information

Drug NameSARS-CoV-2 (Omicron variant) vaccine, Inactivated (Beijing Institute Of Biological Products)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong KongMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChina National Biotec Holding LtdWuhan Institute Of Biological Products Co LtdBeijing Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A